The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada.
- DOI
- 10.1016/j.eclinm.2019.07.001
- Published
- 2019 Aug
- Container
- EClinicalMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2019.07.001,
title = {The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada.},
author = {Zhu J and Rozada I and David J and Moore DM and Guillemi SA and Barrios R and Montaner JSG and Lima VD},
year = {2019},
journal = {EClinicalMedicine},
doi = {10.1016/j.eclinm.2019.07.001},
url = {https://doi.org/10.1016/j.eclinm.2019.07.001}
}RIS
TY - JOUR TI - The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada. AU - Zhu J AU - Rozada I AU - David J AU - Moore DM AU - Guillemi SA AU - Barrios R AU - Montaner JSG AU - Lima VD PY - 2019 JO - EClinicalMedicine DO - 10.1016/j.eclinm.2019.07.001 UR - https://doi.org/10.1016/j.eclinm.2019.07.001 ER -
APA
J, Z., I, R., J, D., DM, M., SA, G., R, B., JSG, M., & VD, L. (2019). The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2019.07.001
Source records
- pubmed · retrieved 2026-09-25T10:44:13.960Z